Related Experiment Video
Updated: Jul 2, 2026
07:27
A Simple Protocol for Platelet-mediated Clumping of Plasmodium falciparum-infected Erythrocytes in a Resource Poor Setting
Published on: May 16, 2013
Platelet factor 4 mediates inflammation in experimental cerebral malaria
Kalyan Srivastava1, Ian A Cockburn, AnneMarie Swaim
1Department of Molecular and Comparative Pathobiology, The Johns Hopkins University School of Medicine, 733 North Broadway, Baltimore, MD 21205, USA.
Cell Host & Microbe
|August 12, 2008
Summary
Platelet factor 4 (PF4) from activated platelets promotes cerebral malaria (CM) severity. Blocking PF4 or depleting platelets reduces experimental CM, highlighting PF4
Area of Science:
- Immunology
- Pathology
- Hematology
Background:
- Cerebral malaria (CM) is a severe complication of Plasmodium falciparum infection in children.
- Pathogenesis involves cerebral capillary obstruction, inflammation, and immune stimulation.
- Platelets play a key role in immune responses and vascular obstruction.
Purpose of the Study:
- To investigate the role of platelet factor 4 (PF4)/CXCL4 in experimental cerebral malaria (ECM).
- To determine if Plasmodium-infected red blood cells (RBCs) activate platelets and increase PF4.
- To assess the impact of PF4 inhibition or platelet depletion on ECM development.
Main Methods:
- Utilized mouse models of experimental cerebral malaria.
- Measured plasma PF4 levels in infected mice.
- Examined ECM severity in PF4 or CXCR3 null mice.
- Assessed the effects of platelet depletion and aspirin treatment on ECM.
Main Results:
- Plasmodium-infected RBCs activated platelets, leading to elevated plasma PF4.
- Mice lacking PF4 or its receptor CXCR3 exhibited less severe ECM.
- Reduced T cell recruitment to the brain was observed in these mice.
- Platelet depletion and aspirin treatment significantly reduced ECM development.
Conclusions:
- Platelet-derived PF4 contributes to the pathogenesis of experimental cerebral malaria.
- PF4 promotes immune activation and T cell trafficking in the brain during ECM.
- Targeting platelet activation or PF4 may offer therapeutic strategies for cerebral malaria.
More Related Videos
12:48Isolation and Analysis of Brain-sequestered Leukocytes from Plasmodium berghei ANKA-infected Mice
Published on: January 2, 2013
09:04In Vivo Tracking of Edema Development and Microvascular Pathology in a Model of Experimental Cerebral Malaria Using Magnetic Resonance Imaging
Published on: June 8, 2017
Related Concept Videos
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
01:18Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:26Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...